Drug Patents in New Zealand: The Hard 20-Year Limit That Shapes Every Generic Entry Decision
The “Hard 20” in New Zealand isn’t just a legal deadline—it’s the metronome for every generic launch decision.
In New Zealand, the patent system has a way of turning uncertainty into timing. And timing, in pharma, is everything.
Drug Patent Watch’s lat…
